Inmune Bio, Inc.
Inmune Bio, Inc. (INMB) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 84 transactions totaling $7.7M, demonstrating a bearish sentiment with -$2.8M in net insider flow. The most recent transaction on Sep 30, 2024 involved a purchase of 10,000 shares valued at $52.9K.
INMB Insider Activity Summary
Who Is Buying INMB Stock?
No significant insider buying has been recorded for INMB in the recent period.
Who Is Selling INMB Stock?
No significant insider selling has been recorded for INMB in the recent period.
Is Inmune Bio, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INMB is bearish with an Insider Alignment Score of 32/100 and a net flow of -$2.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
INMB Frequently Asked Questions
Understanding INMB Insider Activity
Insider trading at Inmune Bio, Inc. (INMB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading INMB stock, having executed 84 transactions in the past 90 days. The most active insider is Inc Xencor (Executive), who has made 4 transactions totaling $10.7M.
Related Tools
Track Inmune Bio, Inc. Insider Activity
Get notified when executives and directors at INMB file new Form 4 transactions